Position Papers & Editorials
European consensus for the diagnosis of MCI and mild dementia: Preparatory phase. (2022)
An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine. (2022)
An EANM position paper on the application of artificial intelligence in nuclear medicine (2022)
Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANM (2022)
2022 follow-up: impact of the COVID-19 pandemic on nuclear medicine departments in Europe (2022)
EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA) (2022)
EANM position on the in-house preparation of radiopharmaceuticals (2022)
Impact of the COVID-19 pandemic on nuclear medicine departments in Europe (2021)
EANM position paper on the role of radiobiology in nuclear medicine (2021)
EANM Focus 3: The International Conference on Molecular Imaging and Theranostics in Neuroendocrine Tumours—the consensus in a nutshell (2021). Official EANM Editorial summarizing the Highlights of the EANM FOCUS 3 consensus meeting publication.
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms (2021). Official EANM consensus paper of FOCUS Meeting 3.
Finding our way through the labyrinth of dementia biomarkers (2021). Official EANM Editorial summarizing the Highlights of the EANM FOCUS 2 consensus meeting publication.
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer’s disease and other dementias (2020). Official EANM consensus paper of FOCUS Meeting 2.
Consensus on molecular imaging and theranostics in prostate cancer (2018). Official EANM consensus paper of FOCUS Meeting 1.